HernandezJ.A., LandK.J., McKennaR.W.Leukemias, myeloma, and other lymphoreticular neoplasms. Cancer.1995; 75: 381–394.
2.
OssermanE.F.Plasma cell myeloma: II. Clinical aspects. N Engl J Med.1959; 261: 952–960.
3.
BolekT.W., MarcusR.B., MendenhallN.P.Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys.1996; 36: 329–333.
4.
KnowlingM.A., HarwoodA.R., BergsagelD.E.Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. J Clin Oncol.1983; 1: 255–262.
5.
BatailleR., SanyJ.Solitary myeloma: clinical and prognostic features of a review of 114 cases. Cancer.1981; 48: 845–851.
6.
FrassicaD.A., FrassicaF.S., SchrayM.F.Solitary plasmacytoma of bone: Mayo Clinic experience. Int J Radiat Oncol Biol Phys.1989; 16: 43–48.
7.
MillW.B., GriffithR.The role of radiation therapy in the management of plasma cell tumors. Cancer.1980; 45: 647–652.
8.
MoulopoulosL.A., DimopoulosM.A., WeberD.Magnetic resonance imaging in the staging of solitary plasmacytoma of bone. J Clin Oncol.1993; 11: 1311–1315.
9.
MoulopoulosL.A., DimopoulosM.A.Magnetic resonance imaging of the bone marrow in hematologic malignancies. Blood.1997; 90: 2127–2147.
MandelliF., AvvisatiG., AmadoriS.Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy. N Engl J Med.1990; 322: 1430–1434.
20.
ClarkeE.Cranial and intracranial myelomas. Brain.1954; 77: 61–81.
